Filing Details

Accession Number:
0001562180-17-001995
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-05-18 16:14:16
Reporting Period:
2017-05-18
Filing Date:
2017-05-18
Accepted Time:
2017-05-18 16:14:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
105770 West Pharmaceutical Services Inc WST Fabricated Rubber Products, Nec (3060) 231210010
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1260426 J William Federici 530 Herman O. West Drive
Exton PA 19341
Sr. Vp & Cfo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-05-18 54,996 $20.85 266,489 No 4 M Direct
Common Stock Disposition 2017-05-18 52,396 $95.42 214,093 No 4 S Direct
Common Stock Disposition 2017-05-18 2,600 $96.00 211,493 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2017-05-18 54,996 $20.85 54,996 $20.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-02-26 2018-02-26 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,039 Indirect By Savings Plan
Common Stock 16,950 Indirect Non-Qualified Deferred Compensation Plan
Footnotes
  1. Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.
  2. The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $95.00 to $95.99, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
  3. The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $96.00 to $96.07, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.